Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
申请人:Abbott Laboratories
公开号:US05358955A1
公开(公告)日:1994-10-25
The present invention relates to a compound of the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein W is selected from optionally substituted pyridyl, naphthyl, and quinolyl; which inhibits lipoxygenase enzyme activity and leukotriene biosynthesis and is useful in the treatment of inflammatory disease states; also disclosed are leukotriene biosynthesis inhibiting compositions and a method for inhibiting lipoxygenase enzyme activity and leukotriene biosynthesis.